Overview
- After SpaceX’s public listing, Rocket Lab shares fell sharply—dropping about 11% on June 12 and roughly 30% from a late‑May peak—reflecting investor rotation toward larger space names and broader re‑pricing of smaller launch stocks.
- The company reported a record first‑quarter revenue of $200.35 million and disclosed a roughly $2.2 billion backlog, giving strong near‑term revenue visibility according to its June financial results.
- Rocket Lab will join the Nasdaq‑100 before trading on June 22, a mechanical catalyst that should force index‑tracking funds to buy shares and that could temporarily support liquidity and price levels.
- Key near‑term risks include Neutron’s delayed maiden flight now expected in Q4 2026 after a propellant tank test failure, an optional up‑to‑$3 billion ATM facility that raises dilution concerns if used, and very high forward P/S multiples priced into expectations.
- Institutional ownership is concentrated at about 71.8% and insiders sold roughly $66.9 million of stock recently, which together with valuation worries and analyst price targets near $103 helps explain why strong results have not translated into sustained share gains.